Your browser doesn't support javascript.
loading
Inherited variants in CHD3 show variable expressivity in Snijders Blok-Campeau syndrome.
van der Spek, Jet; den Hoed, Joery; Snijders Blok, Lot; Dingemans, Alexander J M; Schijven, Dick; Nellaker, Christoffer; Venselaar, Hanka; Astuti, Galuh D N; Barakat, Tahsin Stefan; Bebin, E Martina; Beck-Wödl, Stefanie; Beunders, Gea; Brown, Natasha J; Brunet, Theresa; Brunner, Han G; Campeau, Philippe M; Cuturilo, Goran; Gilissen, Christian; Haack, Tobias B; Hüning, Irina; Husain, Ralf A; Kamien, Benjamin; Lim, Sze Chern; Lovrecic, Luca; Magg, Janine; Maver, Ales; Miranda, Valancy; Monteil, Danielle C; Ockeloen, Charlotte W; Pais, Lynn S; Plaiasu, Vasilica; Raiti, Laura; Richmond, Christopher; Rieß, Angelika; Schwaibold, Eva M C; Simon, Marleen E H; Spranger, Stephanie; Tan, Tiong Yang; Thompson, Michelle L; de Vries, Bert B A; Wilkins, Ella J; Willemsen, Marjolein H; Francks, Clyde; Vissers, Lisenka E L M; Fisher, Simon E; Kleefstra, Tjitske.
Afiliación
  • van der Spek J; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • den Hoed J; Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; International Max Planck Research School for Language Sciences, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
  • Snijders Blok L; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, T
  • Dingemans AJM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Schijven D; Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
  • Nellaker C; Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, United Kingdom; Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom; Big Data Institute, Li Ka Shing Centre
  • Venselaar H; Center for Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Astuti GDN; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Division of Human Genetics, Center for Biomedical Research (CEBIOR), Faculty of Medicine, Diponegoro University, Semarang, Indonesia.
  • Barakat TS; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Bebin EM; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL.
  • Beck-Wödl S; Department of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Beunders G; Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
  • Brown NJ; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Pediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Brunet T; Institute of Human Genetics, School of Medicine, Technical University Munich, Munich, Germany.
  • Brunner HG; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, GROW School for Oncol
  • Campeau PM; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada; Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
  • Cuturilo G; University Children's Hospital Belgrade, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Gilissen C; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Haack TB; Department of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Hüning I; Institute of Human Genetics, University of Lübeck, Lübeck, Germany.
  • Husain RA; Department of Neuropediatrics, Jena University Hospital, Jena, Germany.
  • Kamien B; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Western Australia, Australia.
  • Lim SC; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Lovrecic L; Clinical Institute for Genomic Medicine, University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Magg J; Department of Neuropaediatrics, Developmental Neurology, Social Pediatrics, University Children's Hospital, University of Tübingen, Tübingen, Germany.
  • Maver A; Clinical Institute for Genomic Medicine, University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Miranda V; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada; Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
  • Monteil DC; Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, VA.
  • Ockeloen CW; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Pais LS; Broad Institute Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Plaiasu V; INSMC Alessandrescu-Rusescu, Regional Center of Medical Genetics Bucharest, Bucharest, Romania.
  • Raiti L; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Richmond C; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Genetic Health Queensland, Royal Brisbane and Women's hospital, Herston, Queensland, Australia; School of Medicine, Griffith University, Southport, Queensland, Australia.
  • Rieß A; Department of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Schwaibold EMC; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
  • Simon MEH; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Spranger S; Praxis für Humangenetik-Bremen, Bremen, Germany.
  • Tan TY; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Pediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Thompson ML; HudsonAlpha Institute for Biotechnology, Huntsville, AL.
  • de Vries BBA; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Wilkins EJ; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Willemsen MH; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Francks C; Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands.
  • Vissers LELM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Fisher SE; Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands.
  • Kleefstra T; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands; Center of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray,
Genet Med ; 24(6): 1283-1296, 2022 06.
Article en En | MEDLINE | ID: mdl-35346573
ABSTRACT

PURPOSE:

Common diagnostic next-generation sequencing strategies are not optimized to identify inherited variants in genes associated with dominant neurodevelopmental disorders as causal when the transmitting parent is clinically unaffected, leaving a significant number of cases with neurodevelopmental disorders undiagnosed.

METHODS:

We characterized 21 families with inherited heterozygous missense or protein-truncating variants in CHD3, a gene in which de novo variants cause Snijders Blok-Campeau syndrome.

RESULTS:

Computational facial and Human Phenotype Ontology-based comparisons showed that the phenotype of probands with inherited CHD3 variants overlaps with the phenotype previously associated with de novo CHD3 variants, whereas heterozygote parents are mildly or not affected, suggesting variable expressivity. In addition, similarly reduced expression levels of CHD3 protein in cells of an affected proband and of healthy family members with a CHD3 protein-truncating variant suggested that compensation of expression from the wild-type allele is unlikely to be an underlying mechanism. Notably, most inherited CHD3 variants were maternally transmitted.

CONCLUSION:

Our results point to a significant role of inherited variation in Snijders Blok-Campeau syndrome, a finding that is critical for correct variant interpretation and genetic counseling and warrants further investigation toward understanding the broader contributions of such variation to the landscape of human disease.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN Helicasas / Complejo Desacetilasa y Remodelación del Nucleosoma Mi-2 / Trastornos del Neurodesarrollo Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: ADN Helicasas / Complejo Desacetilasa y Remodelación del Nucleosoma Mi-2 / Trastornos del Neurodesarrollo Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos